Literature DB >> 20141613

Stimulation of protein kinase C-alpha suppresses colon cancer cell proliferation by down-regulation of beta-catenin.

Jungsug Gwak1, Soo-Jin Jung, Dong-Ii Kang, Eun-Young Kim, Dong-Eun Kim, Young-Hwa Chung, Jae-Gook Shin, Sangtaek Oh.   

Abstract

We reported previously that protein kinase C-alpha (PKC-alpha) negatively regulates Wnt/beta-catenin signalling pathway. The current study explores the role of PKC-alpha in the regulation of proliferation of colon cancer cells, which contain aberrant up-regulation of intracellular beta-catenin. In colon tissue and cells, an inverse correlation was observed between the expression levels of PKC-alpha and intracellular beta-catenin. Activation of PKC-alpha inhibited beta-catenin response transcription by down-regulation of intracellular beta-catenin and induced phosphorylation of the N-terminal serine and threonine residues (Ser33/Ser37/Thr41) of beta-catenin, marking it for proteasomal degradation, in colon cancer cells. Pharmacological inhibition or depletion of PKC-alpha-abrogated PKC-alpha-mediated beta-catenin down-regulation and phosphorylation in colon cancer cells. Notably, the Ser45 residue of beta-catenin was essential for PKC-alpha-induced beta-catenin down-regulation in colon cancer cells. Moreover, PKC-alpha activation repressed the expression of cyclin D1 and c-myc, which are known beta-catenin target genes, and thus inhibited the growth of colon cancer cells. These findings suggest that PKC-alpha negatively regulates colon cancer cell proliferation viabeta-catenin phosphorylation/down-regulation and may facilitate the development of new strategies to treatment of colon cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20141613      PMCID: PMC9181363          DOI: 10.1111/j.1582-4934.2009.00683.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  40 in total

1.  Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin.

Authors:  K Orford; C Crockett; J P Jensen; A M Weissman; S W Byers
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

Review 2.  c-Myc, genome instability, and tumorigenesis: the devil is in the details.

Authors:  M Wade; G M Wahl
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

3.  Protein kinase C tissue localization in human colonic tumors suggests a role for adenoma growth control.

Authors:  P Kahl-Rainer; R Sedivy; B Marian
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

4.  Adenoma-specific alterations of protein kinase C isozyme expression in Apc(MIN) mice.

Authors:  I K Klein; S R Ritland; L J Burgart; S C Ziesmer; P C Roche; S J Gendler; W E Karnes
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

Review 5.  The oncogenic activation of beta-catenin.

Authors:  P Polakis
Journal:  Curr Opin Genet Dev       Date:  1999-02       Impact factor: 5.578

6.  Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval.

Authors:  Jordi Martínez; Oliver Vögler; Jesús Casas; Francisca Barceló; Regina Alemany; Jesús Prades; Tünde Nagy; Carmela Baamonde; Philip G Kasprzyk; Silvia Terés; Carlos Saus; Pablo V Escribá
Journal:  Mol Pharmacol       Date:  2004-11-05       Impact factor: 4.436

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Protein kinase C activity as marker for colorectal cancer.

Authors:  Y Sakanoue; T Hatada; M Kusunoki; H Yanagi; T Yamamura; J Utsunomiya
Journal:  Int J Cancer       Date:  1991-07-30       Impact factor: 7.396

9.  Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.

Authors:  Meiko Takahashi; Tatsuhiko Tsunoda; Motoharu Seiki; Yusuke Nakamura; Yoichi Furukawa
Journal:  Oncogene       Date:  2002-08-29       Impact factor: 9.867

10.  Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium.

Authors:  M R Frey; J A Clark; O Leontieva; J M Uronis; A R Black; J D Black
Journal:  J Cell Biol       Date:  2000-11-13       Impact factor: 10.539

View more
  17 in total

Review 1.  Protein kinase C and cancer: what we know and what we do not.

Authors:  R Garg; L G Benedetti; M B Abera; H Wang; M Abba; M G Kazanietz
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

2.  Protein kinase C ϵ stabilizes β-catenin and regulates its subcellular localization in podocytes.

Authors:  Michelle Duong; Xuejiao Yu; Beina Teng; Patricia Schroder; Hermann Haller; Susanne Eschenburg; Mario Schiffer
Journal:  J Biol Chem       Date:  2017-05-24       Impact factor: 5.157

3.  Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.

Authors:  Gwendolyn Barceló-Coblijn; Maria Laura Martin; Rodrigo F M de Almeida; Maria Antònia Noguera-Salvà; Amaia Marcilla-Etxenike; Francisca Guardiola-Serrano; Anja Lüth; Burhard Kleuser; John E Halver; Pablo V Escribá
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

4.  Green tea polyphenol EGCG suppresses Wnt/β-catenin signaling by promoting GSK-3β- and PP2A-independent β-catenin phosphorylation/degradation.

Authors:  Sangtaek Oh; Jungsug Gwak; Seoyoung Park; Chung S Yang
Journal:  Biofactors       Date:  2014-10-29       Impact factor: 6.113

5.  Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.

Authors:  Corina E Antal; Andrew M Hudson; Emily Kang; Ciro Zanca; Christopher Wirth; Natalie L Stephenson; Eleanor W Trotter; Lisa L Gallegos; Crispin J Miller; Frank B Furnari; Tony Hunter; John Brognard; Alexandra C Newton
Journal:  Cell       Date:  2015-01-22       Impact factor: 41.582

6.  Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells.

Authors:  Huan-Tian Zhang; Dabao Zhang; Zhen-Gang Zha; Chang-Deng Hu
Journal:  Biochim Biophys Acta       Date:  2014-10-02

7.  2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy.

Authors:  Silvia Terés; Victoria Lladó; Mónica Higuera; Gwendolyn Barceló-Coblijn; Maria Laura Martin; Maria Antònia Noguera-Salvà; Amaia Marcilla-Etxenike; José Manuel García-Verdugo; Mario Soriano-Navarro; Carlos Saus; Ulises Gómez-Pinedo; Xavier Busquets; Pablo V Escribá
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

Review 8.  The complexities of PKCα signaling in cancer.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Adv Biol Regul       Date:  2020-11-23

9.  Protein kinase C signaling and cell cycle regulation.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Front Immunol       Date:  2013-01-17       Impact factor: 7.561

10.  Small molecule-based promotion of PKCα-mediated β-catenin degradation suppresses the proliferation of CRT-positive cancer cells.

Authors:  Jungsug Gwak; Jee-Hyun Lee; Young-Hwa Chung; Gyu-Yong Song; Sangtaek Oh
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.